Marinomed Biotech AG

Declaration of Voting Results & Voting Rights Announcements • Aug 22, 2024

EQS Voting Rights Announcement: Marinomed Biotech AG Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution 22.08.2024 / 10:00 CET/CEST Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018

Wien, 21.8.2024

Overview

☐ Notification made after deadline

Caution: In case of violations of major holdings notification rules, please pay attention to Section 137 BörseG 2018 (Suspension of voting rights)

1. Issuer: Marinomed Biotech AG

2. Reason for the notification: Acquisition or disposal of voting rights

3. Person subject to notification obligation

Name: LLB Invest Kapitalanlagegesellschaft m.b.H. City: Wien Country: Österreich

4. Name of shareholder(s):

5. Date on which the threshold was crossed or reached: 21.8.2024

6. Total positions

	% of voting rights attached to shares (7.A)	% of voting rights through financial/other instruments (7.B.1 + 7.B.2)	Total of both in % (7.A + 7.B)	Total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed / reached	10,14 %	0,00 %	10,14 %	1 540 530
Position of previous notification (if applicable)	5,02 %		5,02 %

Details

7. Notified details of the resulting situation:

A: Voting rights attached to shares

ISIN Code	Number of voting rights		% of voting rights
	Direct (Sec 130 BörseG 2018)	Indirect (Sec 133 BörseG 2018)	Direct (Sec 130 BörseG 2018)	Indirect (Sec 133 BörseG 2018)
ATMARIONOMED6	156 238		10,14 %
SUBTOTAL A	156 238		10,14 %

B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018

			Number of voting
Type of	Expiration	Exercise	rights that may be	% of voting
instrument	Date	Period	acquired if the	rights
			instrument is
			exercised

B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018

Type of	Expiration	Exercise	Physical /	Number of	% of voting
instrument	Date	Period	Cash	voting	rights
			Settlement	rights

SUBTOTAL B.2

8. Information in relation to the person subject to the notification obligation:

☒ Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

☐ Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

9. In case of proxy voting

Date of general meeting: -

Voting rights after general meeting: - is equivalent to - voting rights.

10. Sonstige Kommentare:

WICHTIG: dies ist eine Korrektur zur heutigen Meldung! Hintergrund: die externen Datenvendoren haben unterschiedliche Daten bzw. Unterschiede in der Anzahl der Aktien/Stimmrechte (Gesamtanzahl).

Die LLB Invest Kapitalanlagegesellschaft m.b.H. hält genannte Aktien als Verwaltungsgesellschaft (KAG) von Investmentfonds. Es gilt hinsichtlich der Zurechnung/Kontrolle die Ausnahme nach § 134 Abs 2 BörseG und § 8 TransV 2018.

Wien am 21.8.2024

22.08.2024 CET/CEST

Language:	English
Company:	Marinomed Biotech AG
	Hovengasse 25
	2100 Korneuburg
	Austria
Internet:	www.marinomed.com

End of News EQS News Service